Participants are being recruited to participate in a research study to test the safety and effectiveness of an FDA approved drug called ceftriaxone for the treatment of ALS. You may be eligible to participate if your ALS symptoms began less than 3 years ago, your breathing is still adequate (we will test it as part of the study) and you have someone (a caregiver) who is available on a daily basis to help you take study medication.
For additional information, please contact Amy Bartlett at (614) 366-9050 or by e-mail at
amy.bartlett@osumc.edu.